|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | American Medical Systems Holdings, Inc. (NASDAQ:AMMD), a supplier of medical devices to cure erectile dysfunction, benign prostatic hyperplasia, incontinence, menorrhagia, prolapse and other pelvic disorders. |
|---|---|
| Transferring Party | Assets of BioControl Medical, Ltd., an Israeli-based developer of medical devices for the application of implantable electrical stimulation technology. |
| Sector | Medical Devices |
| Date | April 26, 2006 |
| Analysis Combines BioControl's implantation technology with American's presence in the urology and gynecological markets to broaden the application of electrical stimulation technology to pelvic health conditions. Deal value with potential milestones - $50m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |